Haoxi Health Technology Limited (HAO)
NASDAQ: HAO · Real-Time Price · USD
1.570
-0.010 (-0.63%)
Jan 22, 2026, 4:00 PM EST - Market closed

Haoxi Health Technology Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
134172---
Market Cap Growth
5.88%-97.87%----
Enterprise Value
6-4172---
Last Close Price
1.571.30133.50---
PE Ratio
1.190.95133.29---
PS Ratio
0.110.113.55---
PB Ratio
0.260.2115.27---
P/TBV Ratio
0.830.2415.27---
EV/Sales Ratio
0.19-3.54---
EV/EBITDA Ratio
--99.29---
EV/EBIT Ratio
--99.90---
Debt / Equity Ratio
0.120.120.110.61-0.34-0.17
Debt / EBITDA Ratio
--0.700.681.380.85
Debt / FCF Ratio
-----0.13
Asset Turnover
1.771.774.8611.289.63-
Inventory Turnover
5.865.8612.0821.4961.73-
Quick Ratio
2.402.401.840.490.210.18
Current Ratio
5.055.053.981.430.220.56
Return on Equity (ROE)
27.06%27.06%20.12%1923.73%--
Return on Assets (ROA)
-6.74%-6.74%10.75%29.85%10.01%-
Return on Invested Capital (ROIC)
-17.34%-22.53%35.85%---
Return on Capital Employed (ROCE)
-11.30%-11.30%14.80%63.30%-18.30%-17.70%
Earnings Yield
30.14%105.66%0.75%---
FCF Yield
-26.10%-91.52%-0.47%---
Buyback Yield / Dilution
-95.84%-95.84%-10.82%-10.45%--
Updated Oct 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q